Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Xa”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01357941
What this trial is testing

Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE)

Who this might be right for
Venous ThromboembolismDeep Vein ThrombosisPulmonary Embolism
Hamilton Health Sciences Corporation 203
Large-scale testing (Phase 3)UnknownNCT00432796
What this trial is testing

PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin.

Who this might be right for
Stroke
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 1,473
Large-scale testing (Phase 3)Study completedNCT00721760
What this trial is testing

Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgery

Who this might be right for
Venous Thromboembolism
Sanofi 1,003
Not applicableStudy completedNCT00114335
What this trial is testing

Epidemiologic Data of Patients in a Teaching Hospital

Who this might be right for
Kidney DiseasesObesity
Luzerner Kantonsspital 352
Testing effectiveness (Phase 2)Study completedNCT01662908
What this trial is testing

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Who this might be right for
Deep Vein ThrombosisVenous Thrombosis
Daiichi Sankyo 85
Large-scale testing (Phase 3)Ended earlyNCT02094157
What this trial is testing

Tapered Warfarin or Interrupted Warfarin With Heparin Bridging for Pacemaker or Defibrillator Implantation

Who this might be right for
Cardiac ArrhythmiasHemorrhageThromboembolism
McMaster University 173
Not applicableUnknownNCT06055907
What this trial is testing

Influence of Vasopressors on Anti-Xa Activity in Critically Ill Patients

Who this might be right for
Critical IllnessThrombosis
Medical University of Gdansk 50
Testing effectiveness (Phase 2)UnknownNCT03139487
What this trial is testing

Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism

Who this might be right for
Cancer-associated ThrombosisEsophageal CancerStomach Cancer+7 more
Asan Medical Center 176
Large-scale testing (Phase 3)UnknownNCT00371020
What this trial is testing

The Effect of 5-FU and LMW Heparin on the Rate of Retinal Redetachment After Silicone Oil Removal in Cases of PVR

Who this might be right for
Proliferative Vitreoretinopathy
Shahid Beheshti University of Medical Sciences
Not applicableStudy completedNCT05256524
What this trial is testing

Is Anti-Factor Xa Associated With Outcome in Patients With Critical COVID-19 on Low-Molecular-Weight Heparin?

Who this might be right for
Covid19ThromboembolismBleeding
Karolinska Institutet 1,520
Not applicableStudy completedNCT04305756
What this trial is testing

Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery

Who this might be right for
ThromboembolismPostpartum DVTThrombosis
University of Utah 146
Large-scale testing (Phase 3)UnknownNCT04999176
What this trial is testing

Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparin

Who this might be right for
CancerRivaroxabanVenous Thromboembolism+1 more
André Luiz Malavasi Longo de Oliveira 440
Large-scale testing (Phase 3)Ended earlyNCT00876915
What this trial is testing

Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients

Who this might be right for
Venous ThromboembolismPulmonary Embolism
University of Rochester 218
Not applicableStudy completedNCT00774748
What this trial is testing

Once Weekly Subcutaneous Ports for the Administration of Anticoagulants

Who this might be right for
Venous Thromboembolism
University of North Carolina, Chapel Hill 21
Not applicableStudy completedNCT01267305
What this trial is testing

The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery

Who this might be right for
Lung NeoplasmsEsophageal NeoplasmsVenous Thromboembolism
Shanghai Zhongshan Hospital 362
Large-scale testing (Phase 3)Study completedNCT00062803
What this trial is testing

SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism

Who this might be right for
Pulmonary Embolism
Sanofi
Large-scale testing (Phase 3)Study completedNCT07124819
What this trial is testing

Dimolegin® (60 mg) Given Once Daily in Patients Undergoing Total Hip or Knee Replacement Compared to Enoxaparin

Who this might be right for
Arthroplasty, Replacement, HipArthroplasty, Replacement, KneeVenous Thromboembolism (VTE)+1 more
Avexima Diol LLC 215
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07499037
What this trial is testing

Safety and Efficacy of Low-dose Anticoagulation With Argatroban and Enoxaparin on ECMO

Who this might be right for
PneumoniaHeart Failure
University Hospital Ostrava 200
Post-approval studies (Phase 4)Looking for participantsNCT07361679
What this trial is testing

LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia Prevention

Who this might be right for
Preeclampsia SevereToxemia Of PregnancyPreeclampsia+3 more
Alexandra Hospital, Athens, Greece 100
Post-approval studies (Phase 4)Study completedNCT01210755
What this trial is testing

Study in Healthy Volunteers of the Reversion by Haemostatic Drugs of the Anticoagulant Effect of New Anti-thrombotics

Who this might be right for
Venous Thromboembolism
University Hospital, Grenoble 10
Next Page